Skip to content

Effect of Post-Puncture Positioning on Postoperative Pain and Quality of Recovery in Patients Undergoing Thoracoscopic Pulmonary Surgery with Intertransverse Process Block

Effect of Post-Puncture Positioning on Postoperative Pain and Quality of Recovery in Patients Undergoing Thoracoscopic Pulmonary Surgery with Intertransverse Process Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125115
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-03
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary nodule

Interventions

ITPB-Supine Position:Supine position of patients following intertransverse process block puncture
ITPB- Lateral Position:Lateral position of patients following intertransverse process block puncture

Sponsors

First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists Classification, Class I to III; 2. Patients aged 18 to 75 years who underwent elective thoracoscopic lobectomy or segmentectomy at our institution; 3. Patients who consented to participate in the study and demonstrated comprehension of relevant assessment items (with voluntarily signed informed consent forms); 4. Body mass index (BMI) ranging from 18.5 to 28 kg/m²;

Exclusion criteria

Exclusion criteria: 1. Contraindications for regional nerve blockade, including but not limited to coagulopathy, infection at the blockade site, and allergy to local anesthetics; 2. Presence of severe organ dysfunction constituting, but not limited to, renal impairment (serum creatinine >442 µmol/L or requirement for renal replacement therapy), hepatic dysfunction (Child-Pugh class C), and major neurological or cardiopulmonary disorders; 3. Patients with a history of chronic pain disorders who required prolonged use of opioid analgesics, corticosteroids, or NSAIDs were excluded; 4. Patients previously enrolled in other clinical studies were excluded;

Design outcomes

Primary

MeasureTime frame
Total Opioid Analgesic Consumption Within 48 Hours Postoperatively (expressed as morphine milligram equivalents, MME);

Secondary

MeasureTime frame
Incidence of agitation during awakening;Postoperative Thirty-Day Mortality;time to first ambulation after surgery;The time of first PCA and the number of rescue analgesia in 48h after surgery;RASS scores at different postoperative time points (5 min postoperatively, 10 min postoperatively, 15 min postoperatively, 20 min postoperatively, 25 min postoperatively, 30 min postoperatively);time to diet after surgery;VAS scores of rest and activity at different time points after surgery (2h, 4h, 8h, 12h, 24h, 48h);Postoperative drain removal time;Skin sensory block segment 20min after completion of block;Opioid Analgesic Consumption during Predefined Postoperative Intervals;Adverse events of the block;Incidence of Pulmonary Complications Within 30 Days Postoperatively;Duration of surgery;Intraoperative Blood Pressure and Heart Rate at Predetermined Time Points;Postoperative 30-Day Pain Outcomes;Duration of Anesthetic Emergence;Onset Time and Duration of Sensory Block;time to exhaust after surgery;Postoperative nausea and vomiting, puncture site infection, itching and other adverse events;Intraoperative Opioid Analgesic Administration;Intraoperative bleeding;Quality of Recovery-15 (QoR-15) Scores at Preoperative Baseline and Postoperative 24-Hour/48-Hour Intervals;Intraoperative blood gas analysis at different time points (before induction of anesthesia, 1 h into surgery, at the end of surgery);Intraoperative infusion volume;

Countries

China

Contacts

Public ContactLifang Zhan

First Affiliated Hospital of Gannan Medical University

zhanlifangzouping@163.com+86 797 828 3990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026